[Childhood onset systemic lupus erythematosus: how does it must be treated in 2010?].
Bader-Meunier
B
B
Service d'Immunologie, Hématologie, Ehumatologie Pédiatriques, Centre National De Référence Arthrites Juvéniles, AP-HP, Hôpital-Necker, Paris, France.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D002648:Child; D019317:Evidence-Based Medicine; D006801:Humans; D006886:Hydroxychloroquine; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008134:Long-Term Care; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008181:Lupus Nephritis / Q000188:drug therapy; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D006886:Hydroxychloroquine; D009173:Mycophenolic Acid